Cytomegalovirus pneumonia in patients with rheumatic diseases after immunosuppressive therapy: A single center study in China

Chinese Medical Journal

Volumn 129, Issue 3, 2016, Pages 267-273

  Xue, Yu ^a,b   Jiang, Li ^c   Wan, Wei Guo ^a,b   Chen, Yu Ming ^a,b   Zhang, Jiong ^a,b   Zhang, Zhen Chun ^b,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Cytomegalovirus; Cytomegalovirus pneumonia; Polymerase chain reaction; Rheumatic disease; Viral load

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISOLONE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHINA; CYTOMEGALOVIRUS INFECTION; DISEASE DURATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MYCOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; VIRUS LOAD; VIRUS PNEUMONIA; CD4+ T LYMPHOCYTE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PNEUMONIA; POLYMERASE CHAIN REACTION; PROCEDURES; RHEUMATIC DISEASES; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CHINA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOSUPPRESSION; PNEUMONIA; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; VIRAL LOAD;

EID: 84955097659     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.174490     Document Type: Article

References (37)

1. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974;17:1-10.
2. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996;39:1475-82.
3. Kadoya A, Okada J, Iikuni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996;23:1186-8.
4. Godeau B, Mainardi JL, Roudot-Thoraval F, Hachulla E, Guillevin L, Huong Du LT, et al. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis 1995;54:991-4.
5. Katz A, Ehrenfeld M, Livneh A, Bank I, Gur H, Pauzner R, et al. Aspergillosis in systemic lupus erythematosus. Semin Arthritis Rheum 1996;26:635-40. doi: 10.1016/S0049-0172(96)80014-X.
6. Manzi S, Kuller LH, Kutzer J, Pazin GJ, Sinacore J, Medsger TA Jr, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol 1995;22:1254-8.
7. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian society of transplantation consensus workshop on Cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005;5:218-27. doi: 10.1111/j.1600-6143.2004.00692.x.
8. Krech U. Complement-fixing antibodies against Cytomegalovirus in different parts of the world. Bull World Health Organ 1973;49:103-6.
9. Radha R, Jordan S, Puliyanda D, Bunnapradist S, Petrosyan A, Amet N, et al. Cellular immune responses to Cytomegalovirus in renal transplant recipients. Am J Transplant 2005;5:110-7. doi: 10.1111/j.1600-6143.2003.00647.x.
10. von Muller L, Klemm A, Durmus N, Weiss M, Suger-Wiedeck H, Schneider M, et al. Cellular immunity and active human Cytomegalovirus infection in patients with septic shock. J Infect Dis 2007;196:1288-95. doi: 101086/522429.
11. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992;80:1358-64.
12. Bek B, Boeckh M, Lepenies J, Bieniek B, Arasteh K, Heise W, et al. High-level sensitivity of quantitative pp65 Cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up. J Clin Microbiol 1996;34:457-9. doi: 10.1016/S0042- 6989(00)00253-4.
13. Machida U, Kami M, Fukui T, Kazuyama Y, Kinoshita M, Tanaka Y, et al. Real-time automated PCR for early diagnosis and monitoring of Cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 2000;38:2536-42. doi: 10.1088/0256-307X/21/6/035.
14. Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, et al. Infection with Cytomegalovirus in patients with inflammatory bowel disease: Prevalence, clinical significance and outcome. J Med Microbiol 2004;53(Pt 11):1155-60. doi: 10.1099/jmm.0.45629-0.
15. Vossen MT, Westerhout EM, Soderberg-Naucler C, Wiertz EJ. Viral immune evasion: A masterpiece of evolution. Immunogenetics 2002;54:527-42. doi: 10.1007/s00251-002-0493-1.
16. Jackson SE, Mason GM, Wills MR. Human Cytomegalovirus immunity and immune evasion. Virus Res 2011;157:151-60. doi: 10.1016/j.virusres.2010.10.031.
17. Aringer M, Smolen JS, Graninger WB. Severe infections in plasmapheresis-treated systemic lupus erythematosus. Arthritis Rheum 1998;41:414-20.
18. Weiss DJ, Greenfield JW Jr, O'Rourke KS, McCune WJ. Systemic Cytomegalovirus infection mimicking an exacerbation of Wegener's granulomatosis. J Rheumatol 1993;20:155-7.
19. Zhang C, Shen K, Jiang Z, He X. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus. Chin Med J 2001;114:1309-12.
20. Shahnaz S, Choksi MT, Tan IJ. Bilateral Cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease. Mayo Clin Proc 2003;78:1412-5. doi: 10.4065/78.11.1412.
21. Sakamoto O, Ando M, Yoshimatsu S, Kohrogi H, Suga M, Ando M. Systemic lupus erythematosus complicated by Cytomegalovirus-induced hemophagocytic syndrome and colitis. Intern Med 2002;41:151-5.
22. Markiewicz M, Smith EA, Rubinchik S, Dong JY, Trojanowska M, LeRoy EC. The 72-kilodalton IE-1 protein of human Cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts. Clin Exp Rheumatol 2004;22 3 Suppl 33:S31-4.
23. Sekigawa I, Nawata M, Seta N, Yamada M, Iida N, Hashimoto H. Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2002;20:559-64.
24. Mori T, Kameda H, Ogawa H, Iizuka A, Sekiguchi N, Takei H, et al. Incidence of Cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy. J Rheumatol 2004;31:1349-51. doi: 10.1016/j.ejso.2006.03.035.
25. Bulpitt KJ, Brahn E. Systemic lupus erythematosus and concurrent Cytomegalovirus vasculitis: diagnosis by antemortem skin biopsy. J Rheumatol 1989;16:677-80.
26. Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, et al. Clinical characteristics of Cytomegalovirus infection in rheumatic diseases: Multicentre survey in a large patient population. Rheumatology (Oxford) 2008;47:1373-8. doi: 10.1093/rheumatology/ken231.
27. Aglas F, Rainer F, Hermann J, Gretler J, Hüttl E, Domej W, et al. Interstitial pneumonia due to Cytomegalovirus following low-dose methotrexate treatment for rheumatoid arthritis. Arthritis Rheum 1995;38:291-2.
28. Ikura Y, Matsuo T, Ogami M, Yamazaki S, Okamura M, Yoshikawa J, et al. Cytomegalovirus associated pancreatitis in a patient with systemic lupus erythematosus. J Rheumatol 2000;27:2715-7.
29. Fraenkel G, Ross B, Wong HC. Cytomegalovirus retinitis in a patient with rheumatoid arthritis being treated with combination immunosuppressive therapy. Retina 1995;15:169-70.
30. Au K, Reed G, Curtis JR, Kremer JM, Greenberg JD, Strand V, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis 2011;70:785-91. doi: 10.1136/ard.2010.128637.
31. Yoda Y, Hanaoka R, Ide H, Isozaki T, Matsunawa M, Yajima N, et al. Clinical evaluation of patients with inflammatory connective tissue diseases complicated by Cytomegalovirus antigenemia. Mod Rheumatol 2006;16:137-42. doi: 10.1007/s10165-006-0470-x.
32. Palafox Sánchez CA, Satoh M, Chan EK, Carcamo WC, Muñoz Valle JF, Orozco Barocio G, et al. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-Cytomegalovirus antibodies. Arthritis Res Ther 2009;11:R27. doi: 10.1186/ar2621.
33. Doria A, Zampieri S, Sarzi-Puttini P. Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 2008;8:89-91. doi: 10.1016/j.autrev.2008.07.036.
34. Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N, et al. Infections and autoimmunity: The multifaceted relationship. J Leukoc Biol 2010;87:385-95. doi: 10.1189/jlb.0709517.
35. Sester M, Sester U, Gärtner BC, Girndt M, Meyerhans A, Köhler H. Dominance of virus-specific CD8 T cells in human primary Cytomegalovirus infection. J Am Soc Nephrol 2002;13:2577-84. doi: 10.1097/01.ASN.0000030141.41726.52.
36. Bieniek R, Kirby JE, Cheng A, Eichelberger K, Qian Q. Effective use of PCR for the detection of Cytomegalovirus viremia and monitoring therapy in immunocompromised patients. J Lab Med 2011;6:339-43. doi: 10.1309/LMP4IL3XGU6MQJCE.
37. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996;88:4063-71.